<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Thirty-one patients aged over 60 yrs and with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LA) were reviewed for their drug intake </plain></SENT>
<SENT sid="1" pm="."><plain>Twenty-three (73%) were taking <z:chebi fb="1" ids="51323">cinchona alkaloids</z:chebi>, 10 (32%) <z:chebi fb="56" ids="15854">quinine</z:chebi> for night cramps, 11 (35%) <z:chebi fb="0" ids="28593">quinidine</z:chebi> for <z:hpo ids='HP_0011675'>cardiac arrhythmia</z:hpo> and 2 (6%) were taking both </plain></SENT>
<SENT sid="2" pm="."><plain>These frequencies of <z:e sem="disease" ids="C0242510" disease_type="Mental or Behavioral Dysfunction" abbrv="">drugs usage</z:e> differed significantly from age and sex matched controls (p &lt; 0.001) </plain></SENT>
<SENT sid="3" pm="."><plain>Five patients had features suggestive of the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Repeat testing showed persistent LA activity in <z:hpo ids='HP_0000001'>all</z:hpo> but 2 of 5 patients in whom the relevant drug had been ceased </plain></SENT>
<SENT sid="5" pm="."><plain>This is the first description of a possible causal association between LA and <z:chebi fb="56" ids="15854">quinine</z:chebi> therapy </plain></SENT>
</text></document>